Desantis M - Search Results

1

Interstitial hypertension in superficial metastatic melanomas in humans.

Boucher Y, Kirkwood JM, Opacic D, Desantis M, Jain RK. Boucher Y, et al. Among authors: desantis m. Cancer Res. 1991 Dec 15;51(24):6691-4. Cancer Res. 1991. PMID: 1742743

2

Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial.

Baur M, Kienzer HR, Schweiger J, DeSantis M, Gerber E, Pont J, Hudec M, Schratter-Sehn AU, Wicke W, Dittrich C. Baur M, et al. Among authors: desantis m. Cancer. 2002 Jun 1;94(11):2953-8. doi: 10.1002/cncr.10574. Cancer. 2002. PMID: 12115384 Free article. Clinical Trial.

3

A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE.

Payne H, Robinson A, Rappe B, Hilman S, De Giorgi U, Joniau S, Bordonaro R, Mallick S, Dourthe LM, Flores MM, Gumà J, Baron B, Duran A, Pranzo A, Serikoff A, Mott D, Herdman M, Pavesi M, De Santis M. Payne H, et al. Int J Cancer. 2022 Mar 1;150(5):837-846. doi: 10.1002/ijc.33845. Epub 2021 Nov 8. Int J Cancer. 2022. PMID: 34648657 Free PMC article.

4

Impact of cytotoxic treatment on long-term fertility in patients with germ-cell cancer.

DeSantis M, Albrecht W, Höltl W, Pont J. DeSantis M, et al. Int J Cancer. 1999 Dec 10;83(6):864-5. doi: 10.1002/(sici)1097-0215(19991210)83:6<864::aid-ijc33>3.0.co;2-e. Int J Cancer. 1999. PMID: 10597213 Review.

5

Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.

De Santis M, Bokemeyer C, Becherer A, Stoiber F, Oechsle K, Kletter K, Dohmen BM, Dittrich C, Pont J. De Santis M, et al. J Clin Oncol. 2001 Sep 1;19(17):3740-4. doi: 10.1200/JCO.2001.19.17.3740. J Clin Oncol. 2001. PMID: 11533096 Clinical Trial.

6

Effective salvage therapy with carboplatin/mitomycin C in metastatic breast cancer.

Baur M, Kienzer H, DeSantis M, Postner G, Pont J, Hudec M, Dittrich C. Baur M, et al. Among authors: desantis m. Onkologie. 2002 Jun;25(3):249-54. doi: 10.1159/000064318. Onkologie. 2002. PMID: 12119459 Clinical Trial.

7

2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.

De Santis M, Becherer A, Bokemeyer C, Stoiber F, Oechsle K, Sellner F, Lang A, Kletter K, Dohmen BM, Dittrich C, Pont J. De Santis M, et al. J Clin Oncol. 2004 Mar 15;22(6):1034-9. doi: 10.1200/JCO.2004.07.188. J Clin Oncol. 2004. PMID: 15020605

8

The role of positron emission tomography in germ cell cancer.

De Santis M, Pont J. De Santis M, et al. World J Urol. 2004 Apr;22(1):41-6. doi: 10.1007/s00345-004-0403-2. Epub 2004 Mar 16. World J Urol. 2004. PMID: 15024601 Review.

9

FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals.

Becherer A, De Santis M, Karanikas G, Szabó M, Bokemeyer C, Dohmen BM, Pont J, Dudczak R, Dittrich C, Kletter K. Becherer A, et al. Eur J Radiol. 2005 May;54(2):284-8. doi: 10.1016/j.ejrad.2004.07.012. Eur J Radiol. 2005. PMID: 15837411 Clinical Trial.

10

Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery.

Sellner F, Tykalsky N, De Santis M, Pont J, Klimpfinger M. Sellner F, et al. Ann Surg Oncol. 2006 Jan;13(1):75-85. doi: 10.1245/ASO.2006.03.064. Epub 2006 Jan 1. Ann Surg Oncol. 2006. PMID: 16372157 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters